Skip to content
DE

Basic metabolic panel: what the blood tests mean

Clinical review pending

What the eight BMP tests measure, how high and low results are interpreted, and why symptoms, medications, and trends matter.

A hand holds an open blank book with three colored windows.

A basic metabolic panel, or BMP, offers a snapshot of blood glucose, kidney function, and the body’s electrolyte balance. What does it mean when a result is flagged? One number rarely supplies the whole answer. Symptoms, medications, the circumstances of the blood draw, and earlier results all help explain what you are seeing.

What a basic metabolic panel measures

A standard BMP includes eight measurements. Together, they provide information about blood glucose regulation, kidney filtration, and electrolyte balance, which influence one another.

Glucose is blood sugar. Sodium, potassium, chloride, and carbon dioxide help assess electrolyte and acid-base balance. Electrolytes are dissolved substances that carry an electrical charge and support functions such as nerve signaling and muscle contraction. Blood urea nitrogen, or BUN, and creatinine help assess kidney function. Calcium contributes to bone health and the function of muscles and nerves. Peacock, 2010

Calcium is one of the eight components of a standard BMP. A seven-test panel that omits calcium is a different grouping, sometimes called a chemistry panel or chem-7. Check the individual tests on your report. The CO₂ result on a BMP mainly reflects bicarbonate, an important acid-base buffer; it is not the same measurement as the partial pressure of CO₂ on a blood gas test.

The results often relate to one another. Persistently high glucose can damage the kidneys over time. Reduced kidney function can disturb electrolyte balance. Potassium also affects how pancreatic beta cells release insulin, linking it to glucose metabolism. These connections explain why clinicians read the pattern rather than treating every number as an isolated finding. Dhondup and Qian, 2017, Chatterjee et al., 2018, Thipsawat, 2021

The panel describes the sample at the time it was collected. A mildly abnormal result may be temporary. Several values moving in an unfavorable direction deserve discussion with your care team, but a single markedly abnormal result can also need prompt attention. Follow any urgent instructions from the laboratory or ordering clinician rather than waiting for every value to change.

What “normal” and “optimal” mean

Laboratory reference ranges describe the results commonly found in a comparison population. They are useful guides, not a dividing line between perfect health and disease. Separate “optimal” ranges for every BMP component are not generally established in clinical guidelines. The midpoint of a range is not automatically a treatment target.

Fasting glucose of 70–99 mg/dL is commonly considered normal. Research has found that higher fasting glucose within the normal range can be associated with greater long-term diabetes risk. That is a risk association, not a diagnosis from a single reading. Creatinine ranges depend partly on muscle mass and sex, making changes over time and the estimated filtration rate important context. Tirosh et al., 2005, American Diabetes Association Professional Practice Committee, 2024

Electrolytes are interpreted together and over time. Sodium, potassium, chloride, and bicarbonate can tell a different story as a group than any one value alone. A result near the middle is not inherently better than one elsewhere within the laboratory’s range. A trend toward either edge may sometimes be worth discussing, particularly after medication changes or alongside symptoms; it is not by itself evidence of a problem.

Age, physical activity, and medical history affect the context. A physically active 25-year-old and a 55-year-old with hypertension may have different histories and treatment needs, without requiring invented age-specific “ideal” electrolyte values. Your earlier results complement the laboratory’s reference interval.

What high results can mean

High results can reflect glucose regulation problems, reduced kidney function, dehydration, or other conditions. Several measurements may change together. The meaning depends on which values are high, how far they are outside the range, and what else is happening.

High glucose can occur with insulin resistance, prediabetes, or diabetes. Insulin resistance means that cells respond less effectively to insulin. Stress, illness, some medications, and eating before an intended fasting test can also raise glucose temporarily. Persistently high glucose is associated with blood vessel damage and injury to the kidneys’ filtering structures. An unexpected result may need confirmation rather than an immediate diagnosis. Dungan et al., 2009, Thipsawat, 2021, American Diabetes Association Professional Practice Committee, 2024

Rising BUN and creatinine can indicate reduced kidney function, although dehydration can increase them too. High sodium more often reflects too little water relative to sodium than simply eating a salty meal; excess sodium can be responsible in particular circumstances. High potassium may result from kidney problems, certain medications, or tissue breakdown. Chloride often changes alongside sodium, although acid-base disorders can alter that relationship. The cited cholera study illustrates severe dehydration and does not establish a universal BUN-to-creatinine pattern for every patient. Adrogué and Madias, 2000, Tariq et al., 2009, Berend et al., 2012, Hunter and Bailey, 2019

A high BMP CO₂ result usually means higher bicarbonate. It can occur with metabolic alkalosis or as compensation for chronic respiratory acidosis; the panel alone cannot distinguish every acid-base disorder. The COPD paper below concerns blood gases and respiratory illness, not a direct equivalence between BMP CO₂ and arterial CO₂ pressure. High calcium can occur with overactive parathyroid glands, some cancers, or excessive vitamin D intake, among other causes. Hussaini et al., 2024, Walker and Shane, 2022

When several values are abnormal, additional testing may clarify the pattern. In someone with diabetes, rising glucose alongside declining estimated glomerular filtration rate (eGFR) or increasing urine albumin can raise concern about kidney damage. Other causes still need consideration. Creatinine alone can miss early kidney disease, especially when muscle mass affects the result. eGFR estimates filtration, while urine albumin provides different information about kidney injury.

What low results can mean

Low results can arise from medication effects, fluid balance, hormonal disorders, or inadequate nutrition. The likely explanation depends on the specific test and the rest of the clinical picture. “Low” does not mean that taking more of the nutrient is automatically the answer.

Low blood glucose is called hypoglycemia. Causes can include glucose-lowering medications, excessive alcohol, liver disease, and hormonal problems. Hypoglycemia may occur after eating or during fasting, but timing alone does not establish its cause. In people without diabetes, evaluation generally depends on documenting compatible symptoms, low glucose, and improvement when glucose rises, rather than labeling hunger or fatigue as hypoglycemia. Cryer et al., 2009, American Diabetes Association Professional Practice Committee, 2024

Low sodium can occur with excess water intake, kidney problems, heart failure, or medications such as diuretics. These drugs alter salt and water handling by the kidneys. Low potassium may involve inadequate intake, losses through diarrhea or diuretic use, and certain hormonal disorders. Low intake alone is not the explanation in every case. Chloride may fall alongside sodium, but the acid-base context matters too. Spasovski et al., 2014, Berend et al., 2012, Hunter and Bailey, 2019

Low total CO₂ can suggest metabolic acidosis, in which bicarbonate is reduced because of an acid-base disturbance. Possible causes include diabetic ketoacidosis, kidney disease, loss of bicarbonate, and excess acid production. Low CO₂ can also occur as compensation for respiratory alkalosis; further testing may be needed. A low BUN result can occur with liver problems, low protein intake or malnutrition, or excess fluid that dilutes the blood. These are different mechanisms, not one shared diagnosis. Matyukhin et al., 2020

Low calcium can be associated with vitamin D deficiency, parathyroid disorders, and other conditions. Total calcium is also affected by albumin: a low total result does not always mean the biologically active, ionized calcium is low. If several electrolytes are low, medications, losses, and chronic illness may affect absorption or retention. The cause determines the response, rather than a blanket recommendation to supplement. Cooper and Gittoes, 2008

How the test is done

A clinician or phlebotomist collects blood, usually from a vein in your arm. The actual collection generally takes only a few minutes, though the visit may take longer. The sample then goes to a laboratory for analysis.

If fasting glucose is requested, you will usually be asked not to eat for 8–12 hours; plain water is generally permitted. Follow the instructions for your particular order, since a BMP does not always require fasting. Ask the practice how to handle medications, especially if you take drugs that can lower glucose. Do not stop prescribed treatment on your own. Meals, stress, exercise, and the timing of collection can affect the results. American Diabetes Association Professional Practice Committee, 2024

Routine results may be available within 24–48 hours, depending on the service. Urgent samples can be processed within hours or sooner in acute care. Automated instruments measure the panel’s components from the blood sample, but release times vary by laboratory and clinical setting.

Repeat testing depends on the condition being monitored and the reason for the test. Someone with diabetes, kidney disease, an electrolyte problem, or a recent medication change may need follow-up; the interval may be shorter or longer than three months. A diabetes monitoring schedule does not automatically mean repeating the entire BMP at every visit. Healthy people do not have a universal requirement for an annual BMP. New symptoms or a substantial health change can alter the timing. American Diabetes Association Professional Practice Committee, 2024

Sample quality also matters. Correct collection and prompt processing help avoid misleading results. Hemolysis, the breakdown of blood cells in the sample, can falsely raise potassium. Dehydration or a recent illness can cause real but temporary changes. A result that does not fit the situation may therefore need a repeat sample, although potentially dangerous abnormalities should be assessed promptly rather than assumed to be a collection error. Meng and Wagar, 2015

What can influence the results?

Diet, medications, stress, and fluid balance can affect the panel. Some influences change the actual concentration of a substance in the bloodstream. Others interfere with measurement or make comparisons with earlier tests less reliable.

High sodium intake can affect fluid balance and blood pressure, while the kidneys usually keep the blood sodium concentration within a narrow range. Low dietary potassium may contribute to inadequate intake, but a low blood potassium result often needs assessment for losses or medication effects. Carbohydrate-containing food raises glucose after eating, with the response shaped by the amount, food structure, and insulin sensitivity. The sodium mortality paper below concerns population sodium intake and cardiovascular risk, not proof that a salty meal directly raises serum sodium. Mozaffarian et al., 2014, Sun and Weaver, 2020, Ludwig, 2002

Different medications change different measurements. Some diuretics lower sodium or potassium; potassium-sparing drugs can have the opposite effect on potassium. ACE inhibitors, used for conditions including hypertension, can raise potassium. Metformin lowers glucose, while glucocorticoids can raise it and affect salt and water balance. Bring an accurate list of prescriptions, over-the-counter medicines, and supplements so the results can be interpreted in context. Spasovski et al., 2014, Hunter and Bailey, 2019, Pernicova and Korbonits, 2014, Perez et al., 2014

Dehydration may concentrate some substances and reduce kidney perfusion, potentially raising sodium, chloride, BUN, or creatinine. Excess fluid can dilute concentrations, though not every measurement changes equally and the pattern depends on the cause. Physical exertion also affects some results, with intensity and duration making a difference. Trying to manipulate a result by drinking excessive water before a test can make it harder to interpret. Adrogué and Madias, 2000

Chronic diabetes, kidney disease, and heart failure may change several values over time. Acute illness, infection, and stress can cause temporary shifts through hormonal and inflammatory responses. Earlier results, symptoms, and the circumstances of collection help separate a temporary fluctuation from a persistent problem.

Which other tests can complement a BMP?

Additional tests are chosen to answer a particular question, rather than ordered simply because more measurements are available. They can help explain a combination of abnormal results or clarify a finding whose significance is uncertain.

Hemoglobin A1c, often called A1C, reflects average glucose exposure over roughly 2–3 months, complementing the single-time-point glucose measurement. Its interpretation can be affected by conditions that alter red blood cells. Creatinine is used to estimate eGFR, giving a more useful assessment of filtration than creatinine alone in many circumstances. Albumin and total protein can provide context about nutrition, liver disease, and fluid balance, but are not direct substitutes for kidney-function testing. Prasad, 2018, Delgado et al., 2022

Magnesium and phosphorus interact with calcium and potassium in cellular function. Liver tests may help when glucose or protein results suggest a broader pattern. Thyroid hormones also influence glucose metabolism and aspects of electrolyte balance. These are possible targeted additions, not a requirement for every person having a BMP. Gröber et al., 2015, Biondi et al., 2019

Fasting insulin and glucose can be used in research estimates such as HOMA, but routine insulin testing is not recommended for most people with diabetes or at risk of diabetes. Urine albumin, usually assessed relative to urine creatinine, can identify kidney injury even when serum creatinine is not elevated. C-peptide reflects the body’s own insulin production and can help clarify diabetes type in selected situations. These tests answer different questions. Matthews et al., 1985, Thipsawat, 2021, Broome et al., 2021

Taken together, results may suggest whether a change is recent or persistent. Higher glucose with a normal A1C could accompany recent stress or illness, among other explanations. A rising A1C despite similar isolated glucose readings may indicate higher average glucose at other times. Such patterns guide further questions; they do not establish the cause by themselves.

What the panel can help with

Appropriately timed testing can reveal some metabolic problems before symptoms appear. It can also help monitor treatment or changes in lifestyle. A BMP does not directly measure how well every intervention is working “at the cellular level,” and a normal panel cannot exclude every health problem.

Prediabetes often has no symptoms but may be detected through glucose testing. Early kidney disease can also be silent, which is one reason eGFR and urine albumin are useful when indicated. Electrolyte disturbances may cause fatigue or muscle symptoms, but these symptoms are nonspecific and do not identify the affected electrolyte. US Preventive Services Task Force et al., 2021, Thipsawat, 2021, Kardalas et al., 2018

Comparing results over time can show whether changes in lifestyle coincide with measurable improvements. Exercise and dietary changes can improve glucose control over months; weight loss can improve insulin sensitivity in people for whom it is appropriate. The size of the response varies, and no particular result is guaranteed. Medication adjustments may also produce changes in the measurements they affect. The cited prevention trial and exercise meta-analysis support specific benefits in their studied populations, not a promise that every BMP value will improve for everyone. Knowler et al., 2002, Umpierre et al., 2011

The panel can document changes during illness, after treatment, or over time. Stable results are reassuring about the measured areas, without proving comprehensive metabolic health. Gradual shifts may prompt an earlier conversation about causes and whether anything needs to change.

Understanding the eight measurements and their limits makes that conversation more useful: which result matters, what might explain it, whether it needs repeating, and how food, activity, or medication fit the picture. The goal is a well-supported next step, not perfect numbers on every line.

Frequently asked questions

What are normal BMP results?

Reference intervals vary by test, method, and laboratory. The following are illustrative adult ranges, not universal diagnostic thresholds or treatment targets:

  • Fasting glucose: 70–99 mg/dL.
  • Sodium: 136–144 mEq/L.
  • Potassium: 3.5–5.0 mEq/L.
  • Chloride: 96–106 mEq/L.
  • Total carbon dioxide (CO₂, mainly bicarbonate): 20–29 mEq/L.
  • Blood urea nitrogen (BUN): 7–20 mg/dL.
  • Creatinine in men: 0.74–1.35 mg/dL.
  • Creatinine in women: 0.59–1.04 mg/dL.
  • Total calcium: approximately 8.5–10.2 mg/dL.

The unit mEq/L describes electrical charge equivalents per liter. Always use the range supplied with your own report. Creatinine depends partly on muscle mass, and total calcium is affected by albumin, among other factors. The midpoint of a reference interval is not an established “optimal” goal for every test.

What is included in a BMP?

A standard BMP contains eight measurements: glucose, sodium, potassium, chloride, total CO₂, BUN, creatinine, and calcium. Calcium is part of the standard panel, rather than an optional eighth item. A seven-test grouping without it is a different panel. Read the report to confirm exactly what was ordered. Together, the results offer information about glucose regulation, kidney function, and electrolyte and acid-base balance.

Does a BMP include A1C?

No. A1C is a separate test reflecting average glucose exposure over approximately 2–3 months. The glucose result in a BMP describes the sample collected at that moment. The two measurements can complement each other but are not interchangeable, and A1C itself has limitations in certain blood disorders and other circumstances.

Do I need to fast for a BMP?

If fasting glucose is requested, a food-free period of 8–12 hours is commonly advised, with plain water usually allowed. Not every BMP requires fasting. Confirm the instructions with the ordering practice, including how to manage medicines. Do not skip prescribed medication simply to prepare for a test without advice.

How often should a BMP be repeated?

It depends on why it was ordered. Kidney disease, diabetes, medication changes, or an electrolyte abnormality may call for follow-up at an individualized interval. Three-month testing is appropriate in some circumstances, but not a universal rule for the entire panel. Nor is an annual BMP automatically necessary for every healthy adult. Symptoms, risks, and prior results guide the decision.

What can change the results?

Food, medications, hydration, and chronic illness can affect measurements. Some diuretics lower sodium or potassium, while other drugs raise potassium. Steroids can raise glucose. Dehydration can increase BUN and creatinine; illness and stress may change several values temporarily. Collection problems such as hemolysis can falsely raise potassium, so sample quality is another part of interpretation.

Which other biomarkers can complement the panel?

A1C provides a longer view of glucose exposure, and eGFR estimates kidney filtration from creatinine and other factors. Urine albumin offers separate information about kidney injury. Magnesium, phosphorus, liver tests, or other measurements may help explain a specific pattern. The useful additions depend on the question being asked, not on maximizing the number of tests.

What if BUN and creatinine both rise?

Reduced kidney function is one possibility, and dehydration can temporarily increase both. A disproportionate BUN increase may involve dehydration or increased protein breakdown, among other explanations. The ratio is not diagnostic on its own and varies by context. Persistent elevations warrant assessment; a marked or rapid change may need prompt attention rather than waiting for the next routine visit.

References

  1. American Diabetes Association Professional Practice Committee (2024). 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes care, 47(Suppl 1), S20-S42. https://doi.org/10.2337/dc24-S002. PubMed

  2. Selvin E, Crainiceanu CM, Brancati FL, Coresh J (2007). Short-term variability in measures of glycemia and implications for the classification of diabetes. Archives of internal medicine, 167(14), 1545-51. https://doi.org/10.1001/archinte.167.14.1545. PubMed

  3. Peacock M (2010). Calcium metabolism in health and disease. Clinical journal of the American Society of Nephrology : CJASN, 5 Suppl 1, S23-30. https://doi.org/10.2215/CJN.05910809. PubMed

  4. Thipsawat S (2021). Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature. Diabetes & vascular disease research, 18(6), 14791641211058856. https://doi.org/10.1177/14791641211058856. PubMed

  5. Dhondup T, Qian Q (2017). Electrolyte and Acid-Base Disorders in Chronic Kidney Disease and End-Stage Kidney Failure. Blood purification, 43(1-3), 179-188. https://doi.org/10.1159/000452725. PubMed

  6. Chatterjee R, Davenport CA, Raffield LM, Maruthur N, Lange L, Selvin E, Butler K, Yeh HC, Wilson JG, Correa A, Edelman D, Hauser E (2018). KCNJ11 variants and their effect on the association between serum potassium and diabetes risk in the Atherosclerosis Risk in Communities (ARIC) Study and Jackson Heart Study (JHS) cohorts. PloS one, 13(8), e0203213. https://doi.org/10.1371/journal.pone.0203213. PubMed

  7. Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, Kochba I, Rudich A, Israeli Diabetes Research Group (2005). Normal fasting plasma glucose levels and type 2 diabetes in young men. The New England journal of medicine, 353(14), 1454-62. https://doi.org/10.1056/NEJMoa050080. PubMed

  8. Dungan KM, Braithwaite SS, Preiser JC (2009). Stress hyperglycaemia. Lancet (London, England), 373(9677), 1798-807. https://doi.org/10.1016/S0140-6736(09)60553-5. PubMed

  9. Tariq M, Memon M, Jafferani A, Shoukat S, Gowani SA, Nusrat R, Riaz M, Patel J, Jamil B, Smego RA (2009). Massive fluid requirements and an unusual BUN/creatinine ratio for pre-renal failure in patients with cholera. PloS one, 4(10), e7552. https://doi.org/10.1371/journal.pone.0007552. PubMed

  10. Adrogué HJ, Madias NE (2000). Hypernatremia. The New England journal of medicine, 342(20), 1493-9. https://doi.org/10.1056/NEJM200005183422006. PubMed

  11. Hunter RW, Bailey MA (2019). Hyperkalemia: pathophysiology, risk factors and consequences. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 34(Suppl 3), iii2-iii11. https://doi.org/10.1093/ndt/gfz206. PubMed

  12. Berend K, van Hulsteijn LH, Gans RO (2012). Chloride: the queen of electrolytes?. European journal of internal medicine, 23(3), 203-11. https://doi.org/10.1016/j.ejim.2011.11.013. PubMed

  13. Hussaini M, Minhaj R, Aishwarya N, Kurapati M, Al Khatib Y, Yousuf Z, Ibrahim Mohamed M, Azam R, A Orfali H, Abdul Mateen M (2024). Analysis of pH, electrolytes and non-invasive respiratory support in COPD with elevated CO. Bioinformation, 20(11), 1503-1507. https://doi.org/10.6026/9732063002001503. PubMed

  14. Walker MD, Shane E (2022). Hypercalcemia: A Review. JAMA, 328(16), 1624-1636. https://doi.org/10.1001/jama.2022.18331. PubMed

  15. Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, Service FJ, Endocrine Society (2009). Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism, 94(3), 709-28. https://doi.org/10.1210/jc.2008-1410. PubMed

  16. Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, Van Biesen W, Nagler E, Hyponatraemia Guideline Development Group (2014). Clinical practice guideline on diagnosis and treatment of hyponatraemia. European journal of endocrinology, 170(3), G1-47. https://doi.org/10.1530/EJE-13-1020. PubMed

  17. Matyukhin I, Patschan S, Ritter O, Patschan D (2020). Etiology and Management of Acute Metabolic Acidosis: An Update. Kidney & blood pressure research, 45(4), 523-531. https://doi.org/10.1159/000507813. PubMed

  18. Cooper MS, Gittoes NJ (2008). Diagnosis and management of hypocalcaemia. BMJ (Clinical research ed.), 336(7656), 1298-302. https://doi.org/10.1136/bmj.39582.589433.BE. PubMed

  19. Meng QH, Wagar EA (2015). Pseudohyperkalemia: A new twist on an old phenomenon. Critical reviews in clinical laboratory sciences, 52(2), 45-55. https://doi.org/10.3109/10408363.2014.966898. PubMed

  20. Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, Lim S, Danaei G, Ezzati M, Powles J, Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (2014). Global sodium consumption and death from cardiovascular causes. The New England journal of medicine, 371(7), 624-34. https://doi.org/10.1056/NEJMoa1304127. PubMed

  21. Sun H, Weaver CM (2020). Rise in Potassium Deficiency in the US Population Linked to Agriculture Practices and Dietary Potassium Deficits. Journal of agricultural and food chemistry, 68(40), 11121-11127. https://doi.org/10.1021/acs.jafc.0c05139. PubMed

  22. Ludwig DS (2002). The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA, 287(18), 2414-23. https://doi.org/10.1001/jama.287.18.2414. PubMed

  23. Pernicova I, Korbonits M (2014). Metformin–mode of action and clinical implications for diabetes and cancer. Nature reviews. Endocrinology, 10(3), 143-56. https://doi.org/10.1038/nrendo.2013.256. PubMed

  24. Perez A, Jansen-Chaparro S, Saigi I, Bernal-Lopez MR, Miñambres I, Gomez-Huelgas R (2014). Glucocorticoid-induced hyperglycemia. Journal of diabetes, 6(1), 9-20. https://doi.org/10.1111/1753-0407.12090. PubMed

  25. Prasad K (2018). Does HbA1cc Play a Role in the Development of Cardiovascular Diseases?. Current pharmaceutical design, 24(24), 2876-2882. https://doi.org/10.2174/1381612824666180903121957. PubMed

  26. Delgado C, Baweja M, Crews DC, Eneanya ND, Gadegbeku CA, Inker LA, Mendu ML, Miller WG, Moxey-Mims MM, Roberts GV, St Peter WL, Warfield C, Powe NR (2022). A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. American journal of kidney diseases : the official journal of the National Kidney Foundation, 79(2), 268-288.e1. https://doi.org/10.1053/j.ajkd.2021.08.003. PubMed

  27. Gröber U, Schmidt J, Kisters K (2015). Magnesium in Prevention and Therapy. Nutrients, 7(9), 8199-226. https://doi.org/10.3390/nu7095388. PubMed

  28. Biondi B, Kahaly GJ, Robertson RP (2019). Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders. Endocrine reviews, 40(3), 789-824. https://doi.org/10.1210/er.2018-00163. PubMed

  29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412-9. https://doi.org/10.1007/BF00280883. PubMed

  30. Broome DT, Pantalone KM, Kashyap SR, Philipson LH (2021). Approach to the Patient with MODY-Monogenic Diabetes. The Journal of clinical endocrinology and metabolism, 106(1), 237-250. https://doi.org/10.1210/clinem/dgaa710. PubMed

  31. US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Krist AH, Kubik M, Li L, Ogedegbe G, Owens DK, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB (2021). Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. JAMA, 326(8), 736-743. https://doi.org/10.1001/jama.2021.12531. PubMed

  32. Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A (2018). Hypokalemia: a clinical update. Endocrine connections, 7(4), R135-R146. https://doi.org/10.1530/EC-18-0109. PubMed

  33. Umpierre D, Ribeiro PA, Kramer CK, Leitão CB, Zucatti AT, Azevedo MJ, Gross JL, Ribeiro JP, Schaan BD (2011). Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA, 305(17), 1790-9. https://doi.org/10.1001/jama.2011.576. PubMed

  34. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England journal of medicine, 346(6), 393-403. https://doi.org/10.1056/NEJMoa012512. PubMed

  35. MedlinePlus. Basic Metabolic Panel (BMP). https://medlineplus.gov/lab-tests/basic-metabolic-panel-bmp/

  36. MedlinePlus. Basic metabolic panel. https://medlineplus.gov/ency/article/003462.htm

  37. MedlinePlus. Carbon Dioxide (CO2) in Blood. https://medlineplus.gov/lab-tests/carbon-dioxide-co2-in-blood/

  38. American Diabetes Association / American Association for Clinical Chemistry (2023). Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. https://doi.org/10.2337/dci23-0036